Genmab — September 2020

[E_L]

I was just wondering Helge, I don't know who you normally get the Symphony Health
data from, but should we expect 1 number for Dara, or a split in Dara IV and Dara Faspro?

[Helge_LarsenPI-redaktør]

Sorry..Link to tweet. https://twitter.com/Genmab/status/1305763362077319169

[Helge_LarsenPI-redaktør]

I receive Symphony Health data from pharma- og biotech investors. I dont know anything about af a evnt. split in Dara IV and Dara Faspro.

[E_L]

ok. I guess we find out next week

[Helge_LarsenPI-redaktør]

Yes.

[E_L]

could use some help on the translation of this chinese article on Amivantamab... https://med.sina.cn/article_detail_103_2_89109.html

[Plimsoller]

Sent you a PM E L.

[Plimsoller]

That didn't go to well Hang on - will send you another one.

[E_L]

thanks, got them, similar to what i get with google tranlator, however wasn't sure what that actually means?

[E_L]

Did they get permission to do those 4 trials in China
? is that what they are saying?

[Plimsoller]

I used Google myself (thought you had issued with their translator), but I just asked a Chinese colleague that question, and she said that they are saying that they have permission.

[E_L]

permission for what ? to do the trial?

[Plimsoller]

Yes.

[E_L]

ok, thanks. and thanks to your colleague

[Plimsoller]

No problem. She is quite impressed that a Dutch guy who doesn't speak Chinese found that article

[Plimsoller]

[E_L]

haha

[Plimsoller]

Just elaborating after she had a second look. it says that the company got persmission from the government to perform the trials. It basically means that the company must have submitted the request to the government bureau beforehand.

[E_L]

i guess that makes sense. you can see in clinicaltrials that they are looking to add a lot of chinese hospitals in the trials, only the first PhI has some recruiting there
already

[Plimsoller]

Big market if they don't copy it